2023
DOI: 10.1097/spc.0000000000000637
|View full text |Cite
|
Sign up to set email alerts
|

Immunotherapy for older patients with cancer

Abstract: Purpose of the review The aim of this review is to describe the clinical use and tolerability of immune checkpoint inhibitors in older adults with solid tumors, where there is an abundance of evidence with recent updates including subgroups of older patients. Recent findings Studies with updated analyses and subgroups of older patients show that in general older patients benefit as well as younger patients and tolerate immunotherapy very well. However, in some instances of combination therapies which may exp… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
3
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
3

Relationship

1
2

Authors

Journals

citations
Cited by 3 publications
(3 citation statements)
references
References 76 publications
0
3
0
Order By: Relevance
“…Hepatocellular carcinoma is a cancer, with 80% of cases diagnosed among patients 70 years or older 26 . Mounting studies distinguish the treatment of cancers between young and elderly people 27 , 28 . Therefore, this study focuses on gut microbiota differences in elderly patients with hepatocellular carcinoma and is the first known gut microbiome study of elderly patients with hepatocellular carcinoma.…”
Section: Discussionmentioning
confidence: 99%
“…Hepatocellular carcinoma is a cancer, with 80% of cases diagnosed among patients 70 years or older 26 . Mounting studies distinguish the treatment of cancers between young and elderly people 27 , 28 . Therefore, this study focuses on gut microbiota differences in elderly patients with hepatocellular carcinoma and is the first known gut microbiome study of elderly patients with hepatocellular carcinoma.…”
Section: Discussionmentioning
confidence: 99%
“…Araujo Vargas et al . 6 reviewed the latest data for immunotherapy treatment in older adults, highlighting the benefits but also recognizing the risks, particularly with combination therapies, that older adults face with these treatments.…”
mentioning
confidence: 99%
“…Immunotherapy has revolutionized cancer care for several tumor sites, and is continually being expanded with new indications and new combinations. Araujo Vargas et al [6] reviewed the latest data for immunotherapy treatment in older adults, highlighting the benefits but also recognizing the risks, particularly with combination therapies, that older adults face with these treatments.…”
mentioning
confidence: 99%